[Fetal outcome following "accidental" administration of a long-acting DTRP6 GnRh depot preparation during the first trimester of pregnancy].
In the case reported here, an injection of DTRP6 GnRh microcapsules was given in the 5th, 9th and 13th week of a spontaneous unsuspected multiple pregnancy. No deleterious effect of the embryo could be demonstrated at birth or six months later.
Rocco
V
V
Divisione di Ostetricia e Ginecologia, Ospedale Landolfi, Solofra, Avellino.
D000328:Adult; D003692:Delayed-Action Preparations / Q000008:administration & dosage; D005260:Female; D005333:Fetus / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D007273:Injections, Intramuscular; D007889:Leiomyoma / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011252:Pregnancy Complications, Neoplastic / Q000000981:diagnostic imaging / Q000188:drug therapy*; D011256:Pregnancy Outcome; D011261:Pregnancy Trimester, First; D011272:Pregnancy, Multiple; D017329:Triptorelin Pamoate / Q000008:administration & dosage / Q000494:pharmacology*; D016216:Ultrasonography, Prenatal; D014594:Uterine Neoplasms / Q000188:drug therapy*
D003692:Delayed-Action Preparations; D017329:Triptorelin Pamoate
Outcome fetale dopo somministrazione "accidentale" di un long acting DTRP6 GnRh in forma deposito durante i primi tre mesi di gestazione.